/
/
/

Astec Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012Jun 2012Mar 2012Dec 2011Sep 2011Jun 2011Mar 2011Dec 2010Sep 2010Jun 2010Mar 2010Dec 2009
₹84 Cr₹159 Cr₹125 Cr₹74 Cr₹91 Cr₹120 Cr₹94 Cr₹99 Cr₹69 Cr₹154 Cr₹51 Cr₹111 Cr₹143 Cr₹127 Cr₹117 Cr₹200 Cr₹184 Cr₹272 Cr₹173 Cr₹103 Cr₹129 Cr₹172 Cr₹116 Cr₹155 Cr₹112 Cr₹181 Cr₹125 Cr₹140 Cr₹77 Cr₹134 Cr₹119 Cr₹113 Cr₹65 Cr₹128 Cr₹74 Cr₹96 Cr₹72 Cr₹91 Cr₹62 Cr₹90 Cr₹70 Cr₹84 Cr₹44 Cr₹72 Cr₹60 Cr₹93 Cr₹57 Cr₹66 Cr₹52 Cr₹47 Cr₹51 Cr₹67 Cr₹42 Cr₹57 Cr₹41 Cr₹44 Cr₹32 Cr₹26 Cr₹29 Cr₹32 Cr₹27 Cr₹22 Cr₹26 Cr₹31 Cr₹31 Cr₹33 Cr₹30 Cr
₹73 L₹3 Cr₹82 L₹1 Cr₹51 L₹79 L₹2 Cr₹2 Cr₹92 L₹2 Cr₹91 L₹98 L₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹7 Cr₹2 Cr₹90 L₹80 L₹2 Cr₹3 Cr₹2 Cr₹1 Cr₹5 Cr₹4 Cr₹2 Cr₹94 L₹6 Cr₹3 Cr₹2 Cr₹47 L₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹92 L₹1 Cr₹34 L₹36 L₹5 Cr₹0₹0₹37 L₹0₹0₹0₹0₹21 L₹0₹0₹17 L₹54 L₹28 L₹3 Cr₹47 L₹7 L₹0₹0₹0₹0₹16 L₹0₹0₹0₹0
₹84 Cr₹161 Cr₹126 Cr₹75 Cr₹92 Cr₹120 Cr₹96 Cr₹101 Cr₹70 Cr₹156 Cr₹52 Cr₹112 Cr₹145 Cr₹130 Cr₹121 Cr₹204 Cr₹187 Cr₹279 Cr₹175 Cr₹103 Cr₹129 Cr₹173 Cr₹119 Cr₹157 Cr₹113 Cr₹186 Cr₹129 Cr₹142 Cr₹78 Cr₹140 Cr₹122 Cr₹115 Cr₹65 Cr₹130 Cr₹76 Cr₹98 Cr₹75 Cr₹91 Cr₹64 Cr₹91 Cr₹71 Cr₹89 Cr₹44 Cr₹72 Cr₹60 Cr₹93 Cr₹57 Cr₹66 Cr₹52 Cr₹47 Cr₹51 Cr₹67 Cr₹43 Cr₹58 Cr₹41 Cr₹47 Cr₹33 Cr₹26 Cr₹29 Cr₹32 Cr₹27 Cr₹22 Cr₹27 Cr₹31 Cr₹31 Cr₹33 Cr₹30 Cr
₹95 Cr₹161 Cr₹132 Cr₹91 Cr₹114 Cr₹126 Cr₹111 Cr₹130 Cr₹125 Cr₹150 Cr₹78 Cr₹123 Cr₹149 Cr₹129 Cr₹114 Cr₹175 Cr₹168 Cr₹217 Cr₹140 Cr₹90 Cr₹110 Cr₹140 Cr₹107 Cr₹132 Cr₹90 Cr₹144 Cr₹110 Cr₹131 Cr₹76 Cr₹116 Cr₹104 Cr₹94 Cr₹60 Cr₹101 Cr₹65 Cr₹85 Cr₹66 Cr₹79 Cr₹53 Cr₹71 Cr₹62 Cr₹72 Cr₹60 Cr₹63 Cr₹49 Cr₹75 Cr₹49 Cr₹54 Cr₹47 Cr₹42 Cr₹46 Cr₹60 Cr₹38 Cr₹52 Cr₹38 Cr₹41 Cr₹30 Cr₹25 Cr₹28 Cr₹30 Cr₹23 Cr₹23 Cr₹24 Cr₹27 Cr₹26 Cr₹28 Cr₹23 Cr
₹6 L₹12 Cr₹5 Cr-₹6 Cr-₹10 Cr₹6 Cr-₹4 Cr-₹18 Cr-₹45 Cr₹15 Cr-₹17 Cr-₹2 Cr₹5 Cr₹8 Cr₹16 Cr₹37 Cr₹28 Cr₹72 Cr₹45 Cr₹22 Cr₹25 Cr₹40 Cr₹19 Cr₹31 Cr₹30 Cr₹48 Cr₹25 Cr₹17 Cr₹7 Cr₹29 Cr₹24 Cr₹25 Cr₹9 Cr₹33 Cr₹15 Cr₹16 Cr₹12 Cr₹17 Cr₹13 Cr₹24 Cr₹12 Cr₹20 Cr-₹12 Cr₹13 Cr₹14 Cr₹19 Cr₹12 Cr₹15 Cr₹9 Cr₹9 Cr₹9 Cr₹11 Cr₹8 Cr₹9 Cr₹6 Cr₹9 Cr₹5 Cr₹3 Cr₹4 Cr₹4 Cr₹5 Cr₹1 Cr₹4 Cr₹5 Cr₹6 Cr₹6 Cr₹7 Cr
₹8 Cr₹8 Cr₹7 Cr₹8 Cr₹11 Cr₹10 Cr₹10 Cr₹9 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹93 L₹1 Cr₹92 L₹55 L₹1 Cr
-₹19 Cr-₹8 Cr-₹16 Cr-₹24 Cr-₹33 Cr-₹16 Cr-₹25 Cr-₹39 Cr-₹62 Cr-₹93 L-₹32 Cr-₹18 Cr-₹11 Cr-₹6 Cr₹1 Cr₹25 Cr₹15 Cr₹58 Cr₹33 Cr₹12 Cr₹17 Cr₹32 Cr₹11 Cr₹24 Cr₹22 Cr₹40 Cr₹16 Cr₹8 Cr-₹2 Cr₹20 Cr₹15 Cr₹18 Cr₹2 Cr₹27 Cr₹13 Cr₹10 Cr₹6 Cr₹4 Cr₹4 Cr₹15 Cr₹5 Cr₹15 Cr-₹23 Cr-₹3 Cr₹7 Cr-₹2 Cr₹5 Cr₹8 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹2 Cr₹4 Cr₹37 L₹4 Cr₹81 L-₹1 Cr₹16 L₹31 L₹2 Cr-₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹5 Cr
-₹19 Cr-₹8 Cr-₹16 Cr-₹24 Cr-₹33 Cr-₹16 Cr-₹40 Cr-₹39 Cr-₹40 Cr-₹96 L-₹24 Cr-₹13 Cr-₹8 Cr-₹5 Cr₹85 L₹18 Cr₹11 Cr₹43 Cr₹25 Cr₹9 Cr₹13 Cr₹24 Cr₹7 Cr₹18 Cr₹16 Cr₹31 Cr₹12 Cr₹5 Cr-₹1 Cr₹13 Cr₹10 Cr₹12 Cr₹1 Cr₹17 Cr₹7 Cr₹7 Cr₹4 Cr₹3 Cr₹71 L₹11 Cr₹4 Cr₹6 Cr-₹17 Cr-₹1 Cr₹5 Cr₹3 Cr₹4 Cr₹6 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹3 Cr₹3 L₹3 Cr₹19 L-₹87 L₹3 L₹28 L₹2 Cr-₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr

Share Price Live Stats

Open (₹)581.80
Volume (₹)17,595.00
High (₹)581.80
Upper Circuit687.90
Low (₹)564.40
Lower Circuit458.60
Prev Close573.25
52W High (₹)941.75
Price566.95
52W Low (₹)513.40

Share Market Cap & Key Ratios Overview

M.Cap (₹)1281.04 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.15
Price to Book3.08
Book Value175.25
EPS (TTM)-29.89
Face Value10.00
ROE (%)-25.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
PIINDNSE
SUMICHEMNSE
BAYERCROPNSE
SHARDACROPNSE
DHANUKANSE
RALLISNSE
NACLINDNSE
BHAGCHEMNSE
GSPCROPNSE
BHARATRASNSE
ASTECNSE
LTP
1W Low
1W High
Market cap (₹)
2463.4+43.3 (1.79%)
2353.50
2509
36,261Cr
499.4-18.45 (-3.56%)
495.40
523
24,892Cr
3983.7-65 (-1.61%)
3935
4074.40
17,777Cr
778.5-5.25 (-0.67%)
763.40
791.75
6,971Cr
1000.25+24.15 (2.47%)
956
1016
4,488Cr
210.5+0.87 (0.42%)
204.51
213
4,082Cr
166.64-4.99 (-2.91%)
165.21
174.38
3,902Cr
268-9.9 (-3.56%)
264.75
285.95
3,462Cr
620.6-6 (-0.96%)
597.15
645.95
2,913Cr
1191.6-63.6 (-5.07%)
1179
1259.60
1,970Cr
566.95-14.5 (-2.49%)
553.05
585
1,281Cr

Key Highlights of Astec Lifesciences Ltd’s P&L

In 2026-03-31, Astec Lifesciences Ltd reported total revenue of ₹453.22Cr, compared with ₹386.93Cr in 2025-03-31, reflecting Astec Lifesciences Ltd turnover.

Depreciation was ₹44.92Cr and finance costs were ₹34.53Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹81Cr in 2026-03-31 as compared to ₹-₹140.99Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹80.92Cr in 2026-03-31 compared with ₹-₹134.75Cr in 2025-03-31.

Earnings per share (EPS) were ₹-36.31 in 2026-03-31, compared with ₹-68.71 in 2025-03-31.